[Federal Register Volume 86, Number 42 (Friday, March 5, 2021)]
[Notices]
[Page 12959]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-04513]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; PAR 20-117: Maximizing Investigators' Research Award (MIRA) 
for Early Stage Investigators (R35--Clinical Trial Optional).
    Date: March 30-31, 2021.
    Time: 9:30 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Manas Chattopadhyay, Ph.D., Scientific Review 
Officer, National Institute of General Medical Sciences, National 
Institutes of Health, Building 45, Room 3An12N, 45 Center Drive, 
Bethesda, MD 20892, 301-827-5320, <a href="/cdn-cgi/l/email-protection#5a373b343b29391a373b333674343332743d352c"><span class="__cf_email__" data-cfemail="204d414e415343604d41494c0e4e49480e474f56">[email protected]</span></a>.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Fellowship: Infectious Disease and Immunology B.
    Date: March 31-April 1, 2021.
    Time: 9:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Uma Basavanna, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Bethesda, MD 20892, 301-435-1199, 
<a href="/cdn-cgi/l/email-protection#2c59414d024e4d5f4d5a4d42424d6c424544024b435a"><span class="__cf_email__" data-cfemail="17627a763975766476617679797657797e7f39707861">[email protected]</span></a>.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Topics in Coronavirus Drug Discovery and Development.
    Date: March 31-April 1, 2021.
    Time: 9:30 a.m. to 6:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Neerja Kaushik-Basu, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 3198, MSC 7808, Bethesda, MD 
20892, (301)435-1742, <a href="/cdn-cgi/l/email-protection#93f8f2e6e0fbfaf8f1f2e0e6fdd3f0e0e1bdfdfafbbdf4fce5"><span class="__cf_email__" data-cfemail="03686276706b6a68616270766d436070712d6d6a6b2d646c75">[email protected]</span></a>.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; NIH Research Enhancement Award (R15) in Oncological Sciences.
    Date: March 31, 2021.
    Time: 10:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Svetlana Kotliarova, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 6214, Bethesda, MD 20892, 301-
594-7945, <a href="/cdn-cgi/l/email-protection#e48f8b90888d859697a489858d88ca8a8d8cca838b92"><span class="__cf_email__" data-cfemail="5d36322931343c2f2e1d303c343173333435733a322b">[email protected]</span></a>.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; PAR-20-140: Catalytic Tool and Technology Development in 
Kidney, Urologic and Hematologic Diseases (R21).
    Date: March 31, 2021.
    Time: 10:00 a.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Atul Sahai, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 2188, MSC 7818, Bethesda, MD 20892, 301-435-
1198, <a href="/cdn-cgi/l/email-protection#7300121b121a12331000015d1d1a1b5d141c05"><span class="__cf_email__" data-cfemail="b9cad8d1d8d0d8f9dacacb97d7d0d197ded6cf">[email protected]</span></a>.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Member Conflict: Vascular Physiology and Pathology.
    Date: March 31, 2021.
    Time: 1:00 p.m. to 3:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Bukhtiar H. Shah, DVM, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 4120, MSC 7802, Bethesda, MD 
20892, (301) 806-7314, <a href="/cdn-cgi/l/email-protection#75061d141d17351606075b1b1c1d5b121a03"><span class="__cf_email__" data-cfemail="6a19020b02082a09191844040302440d051c">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, 
National Institutes of Health, HHS)

    Dated: February 26, 2021.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-04513 Filed 3-4-21; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>